You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Small Cell Lung Carcinoma

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)

Not yet recruiting
  • Non-Small-Cell Lung Carcinoma
  • +2 more
  • Liquid biopsy
  • (no location specified)
Jan 24, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Small Cell Lung Cancer, Angiogenesis, Chemo Effect Trial (Surufatinib, Irinotecan)

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Nov 27, 2022

Toripalimab, First-line Treatment Trial in Guangzhou (EP/EC+PD-1)

Recruiting
  • Toripalimab
  • First-line Treatment
  • Guangzhou, Guangdong, China
    Sun Yat-sen University cancer center
Mar 7, 2023

Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • quaratusugene ozeplasmid
  • atezolizumab
  • (no location specified)
Jan 19, 2023

Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jun 5, 2023

Lung Cancer, Small Cell Lung Carcinoma, Non Small Cell Lung Cancer Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T Infusion)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • iC9.GD2.CAR.IL-15 T Infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Nov 16, 2022

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023

Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jun 6, 2023

Small Cell Lung Cancer Trial in Changchun (BL-B01D1, SI-B003)

Not yet recruiting
  • Small Cell Lung Cancer
  • Changchun, Jilin, China
    Jilin Cancer Hospital
Jun 21, 2023

NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extra-Pulmonary Small Cell Carcinomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Small Cell Lung Cancer, Platinum-Sensitive Lung Small Cell Carcinoma, Extensive-stage Small-cell Lung Cancer Trial in Bordeaux

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • Association of lurbinectedin and durvalumab
  • Association of carboplatin and etoposide
  • Bordeaux, France
    Institut Bergonié
Oct 5, 2022

Non-small Cell Lung Carcinoma Trial (BPI-361175)

Not yet recruiting
  • Non-small Cell Lung Carcinoma
  • (no location specified)
Oct 18, 2022

Durvalumab in Combination With Standard Chemotherapy of

Recruiting
  • Small-cell Lung Cancer
  • Extensive-stage Small-cell Lung Cancer
    • Néo Fáliro, Greece
      Metropolitan Hospital
    Mar 7, 2023

    Lung Cancer, Small-cell Lung Cancer Trial in Lebanon (Trilaciclib, Lurbinectedin)

    Recruiting
    • Lung Cancer
    • Small-cell Lung Cancer
    • Lebanon, New Hampshire
      Dartmouth Hitchcock Medical Center
    Nov 9, 2022

    Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small

    Recruiting
    • Platinum-Resistant Lung Small Cell Carcinoma
    • +3 more
    • Durvalumab
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 5, 2023

    Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

    Not yet recruiting
    • Carcinoma
    • +7 more
    • XNW5004
    • Pembrolizumab 25 mg/mL Solution for Injection
    • (no location specified)
    Aug 31, 2023

    Small Cell Lung Cancer Trial in Nice (acetazolamide in combination with platinum and etoposide-based radiochemo)

    Recruiting
    • Small Cell Lung Cancer
    • acetazolamide in combination with platinum and etoposide-based radiochemotherapy
    • Nice, France
      Centre Antoine Lacassagne
    Jan 19, 2023

    NSCLC, Small Cell Lung Cancer Trial in Worldwide (Durvalumab, Cisplatin, Carboplatin)

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • Small Cell Lung Cancer
    • Houston, Texas
    • +7 more
    Feb 1, 2023

    Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Jinan, China
    • +2 more
    Sep 10, 2023

    Small Cell Lung Cancer Trial (SC0245, Irinotecan)

    Not yet recruiting
    • Small Cell Lung Cancer
    • (no location specified)
    Feb 7, 2023

    Small Cell Lung Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Winston-Salem (Gemcitabine,

    Completed
    Has Results
    • Small Cell Lung Carcinoma
    • +3 more
    • Winston-Salem, North Carolina
      Wake Forest University Health Sciences
    Sep 6, 2022

    Outcomes ofBrazilian Cohort of Previously Untreated Extensive

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Observational study
    • (no location specified)
    Aug 24, 2023